Development of a new bioengineered patch for promoting in situ cellularization and the regeneration of autologous tissue in cardiovascular surgery

开发一种新型生物工程贴片,用于促进心血管手术中的原位细胞化和自体组织再生

基本信息

  • 批准号:
    15591471
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Biodegradable materials with autologous cell seeding have attracted much interest as potential cardiovascular graft. But, pretreatment of these materials requires a complicated and invasive procedure that carries the risk of infection. To resolve these problems we sought to develop a biodegradable graft material containing collagen microsponge that would permit the regeneration of autologous vessel tissue. The ability of this material to promote in situ cellularization with autologous endothelial an smooth muscle cells was tested with and without precellularization.Poly(lactic-co-glycolic acid) as a biodegradable scaffold was compounded with collagen microsponge to form a vascular patch material. These poly(lactic-co-glycolic acid)-collagen patches with or without autologous vessel cellularization were used to patch the canine pulmonary artery trunk. Histologic and biochemical assessment were performed 2 and 6 months after the implantation.There was no thrombus formation in either group, and the poly(lactic-co-glycolic acid) scaffold was almost completely absorbed in both groups. Histologic results showed the formation of an endothelial cell monolayer, a parallel alignment of smooth muscle cells, and reconstructed vessel wall with elastin and collagen fibers. The cellular and extracellular components in the patch had increased to levels similar to those in native tissue at 6 months.The poly(lactic-co-glycolic acid)-collagen microsponge patch with and without precellularization showed good histological findings and durability. This patch shows promise as a bioengineered material for accelerate in situ cellularization and the regeneration of autologous tissue in cardiovascular surgery.
自体细胞种植的生物可降解材料作为潜在的心血管移植物引起了广泛的兴趣。但是,这些材料的预处理需要复杂和侵入性的程序,有感染的风险。为了解决这些问题,我们试图开发一种含有胶原微海绵的可生物降解的移植材料,该材料可以使自体血管组织再生。将聚乳酸-羟基乙酸共聚物(PLA)作为生物可降解支架材料,与胶原微海绵复合,制备成血管补片材料。这些聚(乳酸-羟基乙酸)-胶原补片(有或没有自体血管细胞化)用于修补犬肺动脉干。植入后2个月和6个月进行组织学和生化评估,两组均无血栓形成,两组聚乳酸-羟基乙酸共聚物支架几乎完全吸收。组织学结果显示形成了内皮细胞单层,平滑肌细胞平行排列,血管壁由弹性蛋白和胶原纤维重建。6个月时,补片中的细胞和细胞外成分增加到与天然组织相似的水平。具有和不具有预细胞化的聚(乳酸-羟基乙酸)-胶原微海绵补片显示出良好的组织学结果和耐久性。这种补片显示出作为生物工程材料的前景,用于加速心血管手术中的原位细胞化和自体组织再生。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ICHIKAWA Hajime其他文献

ICHIKAWA Hajime的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ICHIKAWA Hajime', 18)}}的其他基金

Minimally-immunogenic Decellularized Porcine Valve Provides In-situ Recellularization in a Stentless Bioprosthetic Valve
最小免疫原性脱细胞猪瓣膜在无支架生物瓣膜中提供原位再细胞化
  • 批准号:
    17390380
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Electrospun hollow fibres for muscle tissue engineering in a soft bioreactor chamber
用于软生物反应器室肌肉组织工程的电纺中空纤维
  • 批准号:
    NC/Y500604/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Training Grant
Tissue Engineeringによる消化管内視鏡的粘膜切除術後狭窄予防法の確立
利用组织工程建立预防胃肠内镜粘膜切除术后狭窄的方法
  • 批准号:
    24K11102
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
2023 Biomaterials and Tissue Engineering
2023 生物材料与组织工程
  • 批准号:
    10675948
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Health monitoring of fistulas for dialysis patients using ultrasound scans 1=Biomaterials and tissue engineering 2=Healthcare technologies
使用超声波扫描对透析患者的瘘管进行健康监测 1=生物材料和组织工程 2=医疗保健技术
  • 批准号:
    2871818
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
Tissue Engineering Strategies to Revitalize Allografts
振兴同种异体移植物的组织工程策略
  • 批准号:
    10830613
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Blending Dentin to Dentin: Biometric Hydrogels for Dentin Tissue Engineering
将牙本质与牙本质混合:用于牙本质组织工程的生物识别水凝胶
  • 批准号:
    10795693
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Cold Sintering of Advanced Ceramics and Glass along with Natural Sustainable Materials for Bone Tissue Engineering
先进陶瓷和玻璃以及天然可持续材料的冷烧结用于骨组织工程
  • 批准号:
    2891030
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
Programming and implementation of a clinical trials visual testing app platform for assessment of advances in tissue engineering
用于评估组织工程进展的临床试验视觉测试应用程序平台的编程和实施
  • 批准号:
    2887926
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease Modeling
开发基于胶原蛋白的 3D 生物打印微流体平台,用于血管组织工程和疾病建模
  • 批准号:
    10837289
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Integrating tissue engineering and microfluidics to model the spatial niches of the human endometrium in vitro with guidance from in vivo multiomics data
整合组织工程和微流体,在体内多组学数据的指导下,体外模拟人类子宫内膜的空间生态位
  • 批准号:
    10817471
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了